DS-7300 (B7-H3 DXd-ADC) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): A subgroup analysis of a phase 1/2 multicenter study Meeting Abstract
| Authors: | Patel, M. R.; Johnson, M. L.; Falchook, G. S.; Doi, T.; Friedman, C. F.; Piha-Paul, S. A.; Gutierrez, M.; Shimizu, T.; Cheng, B.; Qian, M.; Qian, X.; Myobatake, Y.; Laadem, A.; Yoshizuka, N.; Hammett, T.; Kirui, J.; Arkenau, H. T. |
| Abstract Title: | DS-7300 (B7-H3 DXd-ADC) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): A subgroup analysis of a phase 1/2 multicenter study |
| Meeting Title: | 2022 ASCO Genitourinary Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 40 |
| Issue: | 6 Suppl. |
| Meeting Dates: | 2022 Feb 17-19 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2022-02-20 |
| Language: | English |
| ACCESSION: | WOS:000771008900089 |
| DOI: | 10.1200/JCO.2022.40.6_suppl.087 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 87 -- Source: Wos |
